-
effectivehealthcare.ahrq.gov/products/transparency-infertility/research-protocol
September 03, 2016 - therapeutic use”[MeSH] OR “Aspartic Acid/therapeutic use”[MeSH] OR “Citrulline/therapeutic use”[MeSH] OR “Flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
September 02, 2016 - therapeutic use”[MeSH] OR “Aspartic
Acid/therapeutic use”[MeSH] OR “Citrulline/therapeutic use”[MeSH] OR
“Flavonoids
-
effectivehealthcare.ahrq.gov/products/plant-based-chronic-pain-treatment/protocol
November 03, 2020 - THC, CBD, terpenes, flavonoids), and specific formulations used
Co-use of other interventions for pain
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
March 29, 2023 - THC, CBD, terpenes,
flavonoids), and specific formulations used
• Co-use of other interventions for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
October 12, 2015 - “Flavonoids/therapeutic!use”[MeSH]!OR!“Adrenal!Cortex!Hormones”[MeSH]!OR!“Ejaculatory!
-
effectivehealthcare.ahrq.gov/products/tinnitus/research-protocol
February 22, 2012 - Current Page Topic Timeline Feb. 17, 2012 Topic Suggestion Feb. 22, 2012 Research Protocol Aug. 23, 2013 Systematic Review Nov. 27, 2013 Disposition of Comments Report Evaluation and Treatment of Tinnitus: A Comparative Effectiveness Review
Research Protocol Archived February 22, 2012 Download Main Document PDF 72…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
February 22, 2012 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: February 22, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Evaluation and Treatment of Tinnitus: A Comparative Effectiveness Review
Source: www.eff…
-
effectivehealthcare.ahrq.gov/sites/default/files/draft-appendixes-plant-based-treatment.pdf
March 01, 2021 - THC, CBD, terpenes,
flavonoids), and specific formulations used
• Co-use of other interventions for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-standardized-library_0.pdf
February 01, 2019 - : exercise,
weight loss, compression
stockings
Medications include: coumarins
(α-benzopyrenes), flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
February 01, 2019 - : exercise,
weight loss, compression
stockings
Medications include: coumarins
(α-benzopyrenes), flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q3.pdf
September 01, 2021 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
April 01, 2022 - tetrahydrocannabinol, cannabidiol, terpenes, flavonoids), and specific formulations used
• Co-use of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
February 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3.pdf
May 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
March 01, 2022 - product, dose or estimated dose, specific compounds (e.g.,
tetrahydrocannabinol, cannabidiol, terpenes, flavonoids